AAOS Now, October 2019
-
Literature Offers Little Direction on the Safety and Efficacy of Low-level Laser Therapy for Back Pain
The Food and Drug Administration (FDA) cleared the Erchonia FX 635, a low-level laser therapy (LLLT) device, for “whole body” pain in July. Part one of this series explored the history and theoretical mechanism of action for such devices. This article explores the available literature regarding
-
AAOS Core Values: Will We Take Them Seriously?
Do you know the Academy’s new core values? Did you know the previous core values? Regardless of the actual words or phrases, do you have a sense of the organizational culture? Are we where we want or need to be?
-
Point/Counterpoint: Effective Implant Development
U.S. orthopaedic surgeons have been behind many of the advances the industry has seen in the past 50 years through involvement with the medical device industry.